Performance funds/ETFs
Fidelity | Fidelity Sustainable Healthcare Dis
The fund aims to provide investors with long-term capital growth, principally through investment in the equity securities of companies throughout the world which are involved in the design, manufacture, or sale of products and services used for or in connection with health care, medicine or biotechnology.
Growth in fund currency
Available documents (NL)
Available documents (EN)
Available documents for this product 
Quote
Quote
€27,84
Quote date
31-03-2026
Performance in EUR
Date
31-03-2026
This year
-7,66%
1 week
1,38%
1 month
-7,48%
3 months
-7,66%
6 months
0,58%
1 year
-10,60%
3 years (annualised)
-1,32%
5 years (annualised)
1,35%
Since start (annualised)
4,68%
Indicators
Standard deviation (3yr)
13,00%
Share ratio (3yr)
-0,24
Beta (3yr)
1,00
Alpha (3yr)
-4,51
Tracking error (3yr)
4,14
Top 10 holdings (28-02-2026)
Eli Lilly and Co
7,47 %
Roche Holding AG
7,19 %
Boston Scientific Corp
6,18 %
AbbVie Inc
5,80 %
AstraZeneca PLC
5,74 %
Stryker Corp
5,58 %
Gilead Sciences Inc
4,32 %
Thermo Fisher Scientific Inc
4,16 %
McKesson Corp
3,54 %
Novartis AG Registered Shares
3,34 %
Fees
Entry fee
0,20%; free with Self Directed Investing Basic
Exit charges
0,20%; free with Self Directed Investing Basic
Estimated ongoing charges
1,05%
Dividend
Dividend paying
Yes
Dividend
€0,02
Ex-dividend date
03-08-2020
Payment date
-
Dividend frequency
Annually
Characteristic
Asset Manager
Fidelity
Asset class
Equities
Investment category
Equities - Healthcare
Active/Passive
Active
Fund code
54302
Fund code fractional orders
54302
Fund manager name
Alex Gold
ISIN
LU0936578961
Sustainable Classification
Art. 8, ESG integration
Sustainability Rating
Domicile
Luxembourg
Currency
EUR
Fund size (mio)
€1.083,11 (31-03-2026)
Cut-off time
15:30:00
Execution date
Yes
Inception date
25-09-2013
Benchmark
MSCI ACWI/Health Care NR EUR
Minimum investment amount
€20
Assortiment
Self Directed Investing Basic, Self Directed Investing Plus, Investment advice